Prim, S.A. (BME:PRM)
Spain · Delayed Price · Currency is EUR 13.20
-0.10 (-0.75%)
At close: Jan 16, 2026
Prim, S.A. Market Cap
Prim, S.A. has a market cap or net worth of €224.61 million as of January 16, 2026. Its market cap has increased by 37.50% in one year.
Market Cap
224.61M
Enterprise Value
228.24M
Revenue
240.68M
Ranking
n/a
PE Ratio
15.53
Stock Price
€13.20
Market Cap Chart
Since March 2, 1998, Prim, S.A.'s market cap has increased from 7.51M to 224.61M, an increase of 2,892.30%. That is a compound annual growth rate of 12.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 224.61M | - |
| Dec 31, 2025 | 224.61M | 37.21% |
| Dec 31, 2024 | 163.70M | -7.91% |
| Dec 29, 2023 | 177.76M | -3.62% |
| Dec 30, 2022 | 184.45M | -26.55% |
| Dec 30, 2021 | 251.13M | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.02B |
| Laboratorios Farmaceuticos Rovi | 3.58B |
| Almirall | 2.84B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.42B |
| Clínica Baviera | 813.41M |
| Oryzon Genomics | 259.82M |
| Atrys Health | 229.14M |